☆ 4.4 Article

Decreased circulating CD73 and adenosine deaminase are associated with disease severity in hospitalized patients with COVID-19

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial

Anthony Raymond Tam et al.

Summary: Combined treatment with interferon beta-1b and remdesivir is more effective than remdesivir alone in the treatment of COVID-19, providing relief for symptoms, reducing viral shedding and hospitalization time, and inducing earlier antibody response in high-risk patients.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Genetics & Heredity

Purinergic signaling elements are correlated with coagulation players in peripheral blood and leukocyte samples from COVID-19 patients

Iago C. Schultz et al.

Summary: This study analyzed gene expression and proteomics data from COVID-19 patients using public datasets, comparing them with healthy individuals or non-COVID-19 patients. The study found that the purinergic signaling pathway is modulated in COVID-19 patients, and specific molecules in the blood are correlated with coagulation processes and clinical features. The results suggest that targeting these biomolecules may help attenuate inflammation and coagulopathy in COVID-19 patients.

JOURNAL OF MOLECULAR MEDICINE-JMM (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

Diana A. Gorog et al.

Summary: COVID-19 predisposes patients to thrombotic and thromboembolic events. Numerous biomarkers have emerged to assess the thrombotic risk in these patients, informing prognosis and predicting thrombosis.

NATURE REVIEWS CARDIOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Purinergic modulation of the immune response to infections

Natalia Eberhardt et al.

Summary: This review provides an overview of the current knowledge of the modulation of innate and adaptive immunity driven by the purinergic system during parasitic, bacterial and viral infections.

PURINERGIC SIGNALLING (2022)

Add to Collection

Article Immunology

Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation

Elena Diaz-Garcia et al.

Summary: CD39 overexpression in COVID-19 patients may indicate dysregulation of purinergic signaling and contribute to thromboinflammation disorder.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Genetics & Heredity

High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity

Gilnei Bruno da Silva et al.

Summary: This study investigated the changes in purinergic signaling and immune response in COVID-19 patients. The results showed altered purinergic signaling in both moderate and severe cases, including increased ATP hydrolysis in platelets and PBMCs, as well as significantly elevated ADP and AMP hydrolysis. The study also observed increased expression of CD39 and CD73 in total leukocytes, along with higher extracellular ATP levels in both groups. Additionally, moderate and severe cases exhibited elevated levels of IL-2, IL-6, IL-10, and IL-17. These findings provide valuable insights into the changes in purinergic signaling and immune response in COVID-19, highlighting the therapeutic potential of the purinergic system as a target for the treatment of SARS-CoV-2 disease.

JOURNAL OF MOLECULAR MEDICINE-JMM (2022)

Add to Collection

Article Multidisciplinary Sciences

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jeremy Manry et al.

Summary: This study investigates the impact of autoimmunity on COVID-19-related deaths and finds that individuals carrying autoantibodies neutralizing type I interferons are at higher risk of death, with the risk decreasing with age.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer

Galina Zhulai et al.

Summary: This review discusses two enzymes, ADK and ADA, that are involved in the reduction of adenosine levels. ADK eliminates adenosine by phosphorylation, while ADA regulates adenosine levels by converting it to inosine. These enzymes play important roles in cancer development and may serve as potential therapeutic targets.

BIOMOLECULES (2022)

Add to Collection

Article Cell Biology

Alterations in CD39/CD73 axis of T cells associated with COVID-19 severity

Gilson P. Dorneles et al.

Summary: This study investigates alterations in purinergic pathways in COVID-19 patients and provides new insights into the immunopathology of the disease. The findings suggest that the purinergic signaling is dysregulated in both mild and severe COVID-19 patients, which may affect immune function. Additionally, increased T-cell apoptosis and decreased purine levels are observed in COVID-19 patients compared to healthy controls.

JOURNAL OF CELLULAR PHYSIOLOGY (2022)

Add to Collection

Article Immunology

Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia

Qian Zhang et al.

Summary: In an international cohort of 112 hospitalized children with COVID-19 pneumonia, 12 children with recessive inborn errors of type I interferon immunity were identified. These deficiencies may contribute to the development of COVID-19 pneumonia in children. Additionally, these deficiencies were not found in individuals without pneumonia from SARS-CoV-2 infection.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Add to Collection

Article Cell Biology

B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19

Nils H. Wildner et al.

Summary: This study utilized 16-color flow cytometry analysis to investigate peripheral B cells in patients with SARS-CoV-2 infection or acute Plasmodium falciparum malaria. The results showed an increase in atypical memory B cells and plasmablasts in these patients, along with changes in specific protein expression on the plasmablasts. These changes were positively correlated with inflammatory markers in COVID-19 patients.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Add to Collection

Article Microbiology

SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon

Maya Shemesh et al.

Summary: Type I interferons play a crucial role in combating viral infections, yet SARS-CoV-2 virus has evolved to disrupt immune defenses by blocking IFN beta production through six genes. Despite reducing pSTAT1 levels, the virus still activates antiviral programs and remains sensitive to added interferon, presenting a therapeutic opportunity.

PLOS PATHOGENS (2021)

Add to Collection

Review Cell Biology

Thrombo-Inflammation: A Focus on NTPDase1/CD39

Silvana Morello et al.

Summary: There is a growing body of evidence supporting the link between inflammation and thrombosis. Platelets play a crucial role in both physiological hemostasis and inflammatory/thrombotic events, with NTPDase1/CD39 emerging as an important molecule in controlling both processes and maintaining the antithrombotic properties of endothelium.

CELLS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

COVID19-clinical presentation and therapeutic considerations

Grace Kenny et al.

Summary: The emergence of the SARS-CoV-2 pandemic in 2020 has created therapeutic challenges, particularly due to abnormal host responses and different pathogenic mechanisms at various stages of clinical COVID-19. Despite research efforts, few effective therapies have been identified, highlighting the challenges in developing treatments for new pandemic infections.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Add to Collection

Article Medicine, General & Internal

Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome A Randomized Clinical Trial

V. Marco Ranieri et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Letter Critical Care Medicine

Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung

Juho Jalkanen et al.

INTENSIVE CARE MEDICINE (2020)

Add to Collection

Article Cell Biology

Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73-Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes

Parimah Ahmadi et al.

CELLS (2020)

Add to Collection

Review Medicine, Research & Experimental

Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases

Jiri Sliva et al.

ADVANCES IN THERAPY (2019)

Add to Collection

Review Immunology

Generation and Function of Non-cell-bound CD73 in Inflammation

Enja Schneider et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Critical Care Medicine

An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome

Eddy Fan et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

Add to Collection

Article Critical Care Medicine

The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study

Geoff Bellingan et al.

LANCET RESPIRATORY MEDICINE (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Soluble Ecto-5′-nucleotidase (5′-NT), Alkaline Phosphatase, and Adenosine Deaminase (ADA1) Activities in Neonatal Blood Favor Elevated Extracellular Adenosine

Matthew Pettengill et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Add to Collection

Article Immunology

IFN-β regulates CD73 and adenosine expression at the blood-brain barrier

Jussi Niemela et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2008)

Add to Collection

Article Immunology

IFN-β protects from vascular leakage via up-regulation of CD73

Jan Kiss et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2007)

Add to Collection

Article Immunology

Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock

G Haskó et al.

JOURNAL OF IMMUNOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.